The Addition of Inhaled Furosemide to Standard Treatment of COPD Exacerbation

Summary

The goal of this randomized controlled trial is to determine the effect of adding inhaled furosemide to the known treatment of patient with Chronic obstructive pulmonary disease (COPD) exacerbation. It primarily aims at studying its effect on: 1. Relief of dyspnea sensation 2. Length of hospital stay Participants will be receiving the standard therapy of COPD exacerbation plus either inhaled furosemide or inhaled saline over 3 days. They will be asked to: * Perform spirometry * Fill in dyspnea score * Do arterial blood gases (ABGs)

Timeline

Start

2023-03

Primary completion

2024-12

Completion

2024-12

Drugs

Indications